l 670596 has been researched along with thromboxane a2 in 8 studies
| Studies (l 670596) | Trials (l 670596) | Recent Studies (post-2010) (l 670596) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 21 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagchus, WM; Bresnahan, BA; Lianos, EA; Roman, RJ | 1 |
| Daniel, EE; Janssen, LJ | 1 |
| Bush, LR; Siegfried, ME | 1 |
| Jones, GL; Lane, CG; O'Byrne, PM | 1 |
| Ethier, D; Evans, J; Gillard, JW; Girard, Y; Guindon, Y; Hamel, P; Letts, G; Léveillé, C; Lord, A; Yoakim-Rancourt, C | 1 |
| Morsing, P; Persson, AE; Stenberg, A | 1 |
| Crankshaw, DJ; Gaspar, V | 1 |
| Beauchamp, MH; Bernier, SG; Chemtob, S; Gobeil, F; Hou, X; Kanai, K; Lepage, G; Morrow, JD; Roberts, LJ; Taber, DF; Varma, DR | 1 |
8 other study(ies) available for l 670596 and thromboxane a2
| Article | Year |
|---|---|
Mesangial cell immune injury: effects of thromboxane receptor antagonism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antilymphocyte Serum; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Eicosanoids; Fatty Acids, Unsaturated; Glomerular Filtration Rate; Glomerular Mesangium; Hydrazines; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2 | 1991 |
Pre- and postjunctional effects of a thromboxane mimetic in canine bronchi.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bronchi; Carbazoles; Dogs; Electrophysiology; In Vitro Techniques; Muscle, Smooth; Neuromuscular Junction; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Thromboxanes | 1991 |
Dual antagonism by L-636,499 of serotonin and thromboxane A2 induced aggregation of canine platelets.
Topics: Animals; Carbazoles; Dibenzothiepins; Dogs; In Vitro Techniques; Ketanserin; Male; Molecular Structure; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Thromboxane A2 | 1990 |
Effect of thromboxane antagonists on ozone-induced airway responses in dogs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Airway Resistance; Animals; Carbazoles; Dogs; Indoles; Infusions, Intravenous; Ozone; Prostaglandin Endoperoxides, Synthetic; Respiratory Hypersensitivity; Thromboxane A2 | 1990 |
Tetrahydrocarbazol-1-acetic acids: new class of thromboxane receptor antagonists.
Topics: Acetates; Animals; Blood Platelets; Carbazoles; Humans; In Vitro Techniques; Muscle Contraction; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Stereoisomerism; Structure-Activity Relationship; Thromboxane A2 | 1989 |
Effect of thromboxane inhibition on tubuloglomerular feedback in hydronephrotic kidneys.
Topics: Animals; Carbazoles; Extracellular Space; Feedback; Hydronephrosis; Imidazoles; Indomethacin; Kidney Glomerulus; Kidney Tubules; Rats; Rats, Inbred Strains; Thromboxane A2 | 1989 |
Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbazoles; Cloprostenol; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Iloprost; In Vitro Techniques; Isoproterenol; Myometrium; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins E, Synthetic; Prostaglandins, Synthetic; Receptors, Prostaglandin; Sheep; Thromboxane A2; Thromboxanes; Uterine Contraction; Vasoconstrictor Agents; Xanthenes; Xanthones | 1995 |
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Brain; Calcium; Calcium Channel Blockers; Carbazoles; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; gamma-Linolenic Acid; Humans; In Vitro Techniques; Microcirculation; Prostaglandin Antagonists; Pyridines; Retinal Vessels; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2001 |